BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Taiwan · Delayed Price · Currency is TWD

29.70

+0.30 (1.02%)

Jul 14, 2026, 12:41 PM CST

-14.90% (1Y)

Market Cap	760.68M -8.6%
Revenue (ttm)	263.81M -13.4%
Net Income	43.39M -3.4%
EPS	1.69 -3.6%
Shares Out	25.61M
PE Ratio	17.60
Forward PE	n/a
Dividend	1.50 (5.10%)
Ex-Dividend Date	Aug 7, 2025

Volume	1,051
Open	30.15
Previous Close	29.40
Day's Range	29.70 - 30.15
52-Week Range	28.00 - 34.80
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory animals in Taiwan and internationally. The company offers lab animals, such as rat, mice, and others, as well as surgical services; and rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment. It also offers reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin tes... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1990

Employees 91

Stock Exchange Taipei Exchange

Ticker Symbol 6662

Full Company Profile

Financial Performance

In 2025, BioLASCO Taiwan's revenue was 262.66 million, a decrease of -10.20% compared to the previous year's 292.50 million. Earnings were 42.43 million, a decrease of -3.63%.

Financial Statements